KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Tax Provisions (2016 - 2025)

Historic Tax Provisions for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $34.0 million.

  • West Pharmaceutical Services' Tax Provisions rose 493.83% to $34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.1 million, marking a year-over-year increase of 1891.63%. This contributed to the annual value of $107.5 million for FY2024, which is 1210.14% down from last year.
  • West Pharmaceutical Services' Tax Provisions amounted to $34.0 million in Q3 2025, which was up 493.83% from $30.2 million recorded in Q2 2025.
  • West Pharmaceutical Services' 5-year Tax Provisions high stood at $44.2 million for Q2 2022, and its period low was $12.0 million during Q3 2021.
  • For the 5-year period, West Pharmaceutical Services' Tax Provisions averaged around $28.4 million, with its median value being $29.4 million (2023).
  • Within the past 5 years, the most significant YoY rise in West Pharmaceutical Services' Tax Provisions was 10187.5% (2021), while the steepest drop was 4312.8% (2021).
  • Over the past 5 years, West Pharmaceutical Services' Tax Provisions (Quarter) stood at $34.2 million in 2021, then fell by 15.5% to $28.9 million in 2022, then increased by 19.38% to $34.5 million in 2023, then rose by 6.67% to $36.8 million in 2024, then dropped by 7.61% to $34.0 million in 2025.
  • Its Tax Provisions was $34.0 million in Q3 2025, compared to $30.2 million in Q2 2025 and $24.1 million in Q1 2025.